| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 10/24/2013 | WO2013158988A1 Point of care cyanide test device and kit |
| 10/24/2013 | WO2013158984A1 Biomarkers to identify patients that will respond to treatment and treating such patients |
| 10/24/2013 | WO2013158939A1 In vitro model for pathological or physiologic conditions |
| 10/24/2013 | WO2013158841A1 Peptide mimotopes to oxidation specific epitopes |
| 10/24/2013 | WO2013158827A1 Method for the detection and quantification of analytes using three-dimensional paper-based devices |
| 10/24/2013 | WO2013158777A1 Method for predicting risk of exposure to interstitial fibrosis and tubular atrophy with clusterin |
| 10/24/2013 | WO2013158553A1 Multivalent breast cancer vaccine |
| 10/24/2013 | WO2013158515A1 Device for monitoring water supply equipment, water purification equipment and solar water heater |
| 10/24/2013 | WO2013158505A1 Device for performing an enzyme-based diagnostic test and methods for use thereof |
| 10/24/2013 | WO2013158494A1 Wide range luminescent immunoassays |
| 10/24/2013 | WO2013158485A1 Menainv and cancer invasion and metastasis |
| 10/24/2013 | WO2013158389A1 Elisa assay kit, elisa for determining desmosine levels from urine samples and diagnostic urine assays for aneurysms |
| 10/24/2013 | WO2013158340A1 Systems and methods for separation and analysis of target analytes |
| 10/24/2013 | WO2013158333A1 Multiplex immunoassay for rheumatoid arthritis and other autoimmune diseases |
| 10/24/2013 | WO2013158277A1 Methods for quantifying polypeptides using mass spectrometry |
| 10/24/2013 | WO2013158265A1 Imaging methods for oncolytic virus therapy |
| 10/24/2013 | WO2013158230A1 Compositions and methods for detecting unstable arteriosclerotic plaques |
| 10/24/2013 | WO2013158203A1 Methods for exosome isolation |
| 10/24/2013 | WO2013158144A1 Method and system of detecting dioxin-like compounds |
| 10/24/2013 | WO2013158045A1 Microfilter and apparatus for separating a biological entity from a sample volume |
| 10/24/2013 | WO2013158021A1 A nanocapillary device for biomolecule detection, a fluidic network structure and a method of manufacturing thereof |
| 10/24/2013 | WO2013157946A1 Method for detecting defects in food products |
| 10/24/2013 | WO2013157910A1 Portable electronic sensor for detecting volatile amines in the exploration of the female genital tract |
| 10/24/2013 | WO2013157652A1 Method for screening a modulator of a tmem16 family member |
| 10/24/2013 | WO2013157642A1 Method for removal of triglycerides in lipoproteins other than low-density lipoproteins |
| 10/24/2013 | WO2013156806A2 Quantitative biomarkers in the erythrocyte membrane |
| 10/24/2013 | WO2013156795A1 An enzyme detection device |
| 10/24/2013 | WO2013156794A1 An enzyme detection device |
| 10/24/2013 | WO2013156552A1 Means and methods for generating improved proteins |
| 10/24/2013 | WO2013156528A1 Method for the selection of serum biomarkers of epigenetic alterations, particularly of global hypomethylation and their uses |
| 10/24/2013 | WO2013156514A1 Process for making biosensor |
| 10/24/2013 | WO2013156156A1 Method for presymptomatic diagnosis of coeliac disease and gluten sensitivity |
| 10/24/2013 | WO2013156142A1 Climbing robot for corrosion monitoring and sensor for potential mapping |
| 10/24/2013 | WO2013155883A1 Hybridoma cell line 3g1 and monoclonal antibody produced thereby against aflatoxin b1 |
| 10/24/2013 | WO2013155882A1 Hybridoma cell line 10g4 and monoclonal antibody produced thereby against sum of aflatoxins b1, b2, g1, and g2 |
| 10/24/2013 | WO2013155728A1 Method for detecting special gas and special gas reconnaissance car for implementing same method |
| 10/24/2013 | WO2013155686A1 APPLICATION OF INTEGRIN β SUBUNIT IN DIAGNOSING VENOUS THROMBOEMBOLISM |
| 10/24/2013 | WO2013155633A1 Method for detecting or monitoring prostate cancer |
| 10/24/2013 | WO2013155617A1 Solid support and method for detecting an analyte in a sample |
| 10/24/2013 | WO2013155614A1 Biomarkers for recovered heart function |
| 10/24/2013 | WO2013155605A1 Method for predicting a pathophysiological condition in an animal |
| 10/24/2013 | WO2013155553A1 Methods and systems for detecting an analyte or classifying a sample |
| 10/24/2013 | WO2013122470A4 Methods of differentiating hypoactive sexual desire disorder and/or female sexual arousal disorder |
| 10/24/2013 | WO2013121193A3 Apparatus comprising an array of sensor wells and an array of flow control wells for improving the wettability and distribution of fluids applied to the surface of the body of the apparatus and method of forming an array of layers of amphiphilic molecules |
| 10/24/2013 | WO2013113744A3 Polypeptide markers for diagnosis and assessment of heart failure |
| 10/24/2013 | WO2013091883A3 Selective ligands for the angiotensin ii receptors |
| 10/24/2013 | WO2013087887A3 Biomarkers and parameters for preeclampsia |
| 10/24/2013 | WO2013072584A3 Method for characterizing circulating tumor cells, and use thereof in diagnosis |
| 10/24/2013 | WO2012159072A4 Fluorescent molecular probes for use in assays that measure test compound competitive binding with sam-utilizing proteins |
| 10/24/2013 | WO2012141554A8 Complex in which anti-cotinine antibody is bound to conjugate of cotinine and binding substance, and use thereof |
| 10/24/2013 | WO2012116809A9 Il-22 as a prognostic and diagnostic marker in rheumatoid arthritis |
| 10/24/2013 | WO2008083493A8 Stabilization of cyclic peptide structures |
| 10/24/2013 | WO2002079385A9 Isolated human ras-like proteins, nucleic acid molecules encoding these human ras-like proteins, and uses thereof |
| 10/24/2013 | WO2002077196A9 Macrolide efflux genetic assembly |
| 10/24/2013 | US20130282321 Calibrating breathalyzer |
| 10/24/2013 | US20130282303 Method for determining a condition indicator of an analysis apparatus |
| 10/24/2013 | US20130282302 Method and System for Providing Real Time Analyte Sensor Calibration with Retrospective Backfill |
| 10/24/2013 | US20130282301 Closed Loop Blood Glucose Control Algorithm Analysis |
| 10/24/2013 | US20130282298 Urine analyzer and urine sample information processing method |
| 10/24/2013 | US20130282296 Low perfusion signal processing systems and methods |
| 10/24/2013 | US20130282293 Method and apparatus for identifying proteins in mixtures |
| 10/24/2013 | US20130282001 Monitoring of Neuromodulation Using Biomarkers |
| 10/24/2013 | US20130281873 Method for measuring breath alcohol concentration and apparatus therefor |
| 10/24/2013 | US20130281519 Method for identifying biologically active oligonucleotides capable of modulating the immune system |
| 10/24/2013 | US20130281503 Modulation of response regulators by imidazole derivatives |
| 10/24/2013 | US20130281482 Nicotinic acetylcholine receptor agonists |
| 10/24/2013 | US20130281440 Ddx3 as a biomarker for cancer and methods related thereto |
| 10/24/2013 | US20130281423 Methods and compositions for ameliorating pancreatic cancer |
| 10/24/2013 | US20130281379 Mutant channelrhodopsin 2 |
| 10/24/2013 | US20130281376 Sparc microenvironment signature, plasma sparc, and ldh as prognostic biomarkers in the treatment of cancer |
| 10/24/2013 | US20130281320 Methods of Screening an Agent for an Activity in an Isolated Eye of a Teleost |
| 10/24/2013 | US20130281318 Design and selection of medicaments that modulate the function and activity of interleukin 13 |
| 10/24/2013 | US20130281317 Constructs and methods to identify antibodies that target glycans |
| 10/24/2013 | US20130281315 Enhancing surface plasmon resonance imaging signal |
| 10/24/2013 | US20130281313 Prognostic and/or predictive biomarkers and biological applications thereof |
| 10/24/2013 | US20130281310 Sensitive immunoassays using coated nanoparticles |
| 10/24/2013 | US20130281309 Novel biomarker for non-alcoholic fatty liver disease, and method for detecting non-alcoholic fatty liver disease by using the biomarker |
| 10/24/2013 | US20130281303 Comprehensive monoclonal antibody generation |
| 10/24/2013 | US20130280821 Method for detecting an infection by hepatitis b virus |
| 10/24/2013 | US20130280820 Biomarkers for psoriasis |
| 10/24/2013 | US20130280816 ApoIII and the Treatment and Diagnosis of Diabetes |
| 10/24/2013 | US20130280814 Method and kit for protein labeling |
| 10/24/2013 | US20130280807 Cell culture chamber, method for producing same, tissue model using cell culture chamber, and method for producing same |
| 10/24/2013 | US20130280795 Sampling and testing device for the human or animal body |
| 10/24/2013 | US20130280755 Therapeutic methods for solid delivery |
| 10/24/2013 | US20130280754 3D Cell Viability Assay |
| 10/24/2013 | US20130280753 In vitro mitochondrial function test (mft) and uses thereof |
| 10/24/2013 | US20130280747 Cell culture apparatus |
| 10/24/2013 | US20130280746 Peptide-lipid constructs and their use in diagnostic and therapeutic applications |
| 10/24/2013 | US20130280740 Methods for Detecting Symmetrical Dimethylarginine |
| 10/24/2013 | US20130280739 Determination of the efficacy of an anti-mycobacterial vaccination |
| 10/24/2013 | US20130280738 Diagnostics for membranous nephropathy |
| 10/24/2013 | US20130280736 Reagents and methods for diagnosing conditions associated with hydroxylated hif 1-alpha |
| 10/24/2013 | US20130280735 Gene Expression Control DNA Element and Associated Protein |
| 10/24/2013 | US20130280733 Biomarkers for the Diagnosis of ALS |
| 10/24/2013 | US20130280732 Diagnostic drug and diagnostic method for alzheimer's disease |
| 10/24/2013 | US20130280730 Canceration information providing method and canceration information providing device |
| 10/24/2013 | US20130280727 Methods for detecting nucleic acids indicative of cancer |
| 10/24/2013 | US20130280719 Method of deriving progenitor cell line |
| 10/24/2013 | US20130280718 Methods and Compositions for Dual Extraction of Protein and Nucleic Acid |